These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22329513)

  • 1. Differential oxidation of two thiophene-containing regioisomers to reactive metabolites by cytochrome P450 2C9.
    Rademacher PM; Woods CM; Huang Q; Szklarz GD; Nelson SD
    Chem Res Toxicol; 2012 Apr; 25(4):895-903. PubMed ID: 22329513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposite behaviors of reactive metabolites of tienilic acid and its isomer toward liver proteins: use of specific anti-tienilic acid-protein adduct antibodies and the possible relationship with different hepatotoxic effects of the two compounds.
    Bonierbale E; Valadon P; Pons C; Desfosses B; Dansette PM; Mansuy D
    Chem Res Toxicol; 1999 Mar; 12(3):286-96. PubMed ID: 10077492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiophene derivatives as new mechanism-based inhibitors of cytochromes P-450: inactivation of yeast-expressed human liver cytochrome P-450 2C9 by tienilic acid.
    López-Garcia MP; Dansette PM; Mansuy D
    Biochemistry; 1994 Jan; 33(1):166-75. PubMed ID: 8286335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative activation of the thiophene ring by hepatic enzymes. Hydroxylation and formation of electrophilic metabolites during metabolism of tienilic acid and its isomer by rat liver microsomes.
    Dansette PM; Amar C; Smith C; Pons C; Mansuy D
    Biochem Pharmacol; 1990 Mar; 39(5):911-8. PubMed ID: 2310416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic studies of the cationic binding pocket of CYP2C9 in vitro and in silico: metabolism of nonionizable analogs of tienilic acid.
    Tay S; Le H; Ford KA; Nelson SD; Khojasteh SC; Rademacher PM
    Drug Metab Dispos; 2014 Nov; 42(11):1955-63. PubMed ID: 25187484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular structure and hepatotoxicity: compared data about two closely related thiophene compounds.
    Mansuy D
    J Hepatol; 1997; 26 Suppl 2():22-5. PubMed ID: 9204406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxylation and formation of electrophilic metabolites of tienilic acid and its isomer by human liver microsomes. Catalysis by a cytochrome P450 IIC different from that responsible for mephenytoin hydroxylation.
    Dansette PM; Amar C; Valadon P; Pons C; Beaune PH; Mansuy D
    Biochem Pharmacol; 1991 Feb; 41(4):553-60. PubMed ID: 1997003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human-liver cytochromes P-450 expressed in yeast as tools for reactive-metabolite formation studies. Oxidative activation of tienilic acid by cytochromes P-450 2C9 and 2C10.
    Lopez Garcia MP; Dansette PM; Valadon P; Amar C; Beaune PH; Guengerich FP; Mansuy D
    Eur J Biochem; 1993 Apr; 213(1):223-32. PubMed ID: 8477697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The substrate binding site of human liver cytochrome P450 2C9: an approach using designed tienilic acid derivatives and molecular modeling.
    Mancy A; Broto P; Dijols S; Dansette PM; Mansuy D
    Biochemistry; 1995 Aug; 34(33):10365-75. PubMed ID: 7654690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative NMR-based metabonomic investigation of the metabolic phenotype associated with tienilic acid and tienilic acid isomer.
    Coen M; Rademacher PM; Zou W; Scott M; Ganey PE; Roth R; Nelson SD
    Chem Res Toxicol; 2012 Nov; 25(11):2412-22. PubMed ID: 23013248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate selectivity of human cytochrome P450 2C9: importance of residues 476, 365, and 114 in recognition of diclofenac and sulfaphenazole and in mechanism-based inactivation by tienilic acid.
    Melet A; Assrir N; Jean P; Pilar Lopez-Garcia M; Marques-Soares C; Jaouen M; Dansette PM; Sari MA; Mansuy D
    Arch Biochem Biophys; 2003 Jan; 409(1):80-91. PubMed ID: 12464247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism-based inactivation of cytochrome P450 2C9 by tienilic acid and (+/-)-suprofen: a comparison of kinetics and probe substrate selection.
    Hutzler JM; Balogh LM; Zientek M; Kumar V; Tracy TS
    Drug Metab Dispos; 2009 Jan; 37(1):59-65. PubMed ID: 18838506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the substrate specificities of human liver cytochrome P450s 2C9 and 2C18: application to the design of a specific substrate of CYP 2C18.
    Minoletti C; Dijols S; Dansette PM; Mansuy D
    Biochemistry; 1999 Jun; 38(24):7828-36. PubMed ID: 10387023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrospray ionization mass spectrometric analysis of intact cytochrome P450: identification of tienilic acid adducts to P450 2C9.
    Koenigs LL; Peter RM; Hunter AP; Haining RL; Rettie AE; Friedberg T; Pritchard MP; Shou M; Rushmore TH; Trager WF
    Biochemistry; 1999 Feb; 38(8):2312-9. PubMed ID: 10029524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diclofenac and its derivatives as tools for studying human cytochromes P450 active sites: particular efficiency and regioselectivity of P450 2Cs.
    Mancy A; Antignac M; Minoletti C; Dijols S; Mouries V; Duong NT; Battioni P; Dansette PM; Mansuy D
    Biochemistry; 1999 Oct; 38(43):14264-70. PubMed ID: 10572000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidation of tienilic acid by human yeast-expressed cytochromes P-450 2C8, 2C9, 2C18 and 2C19. Evidence that this drug is a mechanism-based inhibitor specific for cytochrome P-450 2C9.
    Jean P; Lopez-Garcia P; Dansette P; Mansuy D; Goldstein JL
    Eur J Biochem; 1996 Nov; 241(3):797-804. PubMed ID: 8944768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of in vitro covalent binding of tienilic acid metabolites to human liver microsomes in relationship to the type of hepatotoxicity: comparison with two directly hepatotoxic drugs.
    Lecoeur S; Bonierbale E; Challine D; Gautier JC; Valadon P; Dansette PM; Catinot R; Ballet F; Mansuy D; Beaune PH
    Chem Res Toxicol; 1994; 7(3):434-42. PubMed ID: 8075377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism-based inactivation of human recombinant P450 2C9 by the nonsteroidal anti-inflammatory drug suprofen.
    O'Donnell JP; Dalvie DK; Kalgutkar AS; Obach RS
    Drug Metab Dispos; 2003 Nov; 31(11):1369-77. PubMed ID: 14570769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The substrate binding site of human liver cytochrome P450 2C9: an NMR study.
    Poli-Scaife S; Attias R; Dansette PM; Mansuy D
    Biochemistry; 1997 Oct; 36(42):12672-82. PubMed ID: 9335524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19.
    Ha-Duong NT; Dijols S; Macherey AC; Goldstein JA; Dansette PM; Mansuy D
    Biochemistry; 2001 Oct; 40(40):12112-22. PubMed ID: 11580286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.